Northwestern University Feinberg School of Medicine

Department of Medical Social Sciences

Clinical Trials

Search Studies

Trials
A PHASE 3 SINGLE CENTER STUDY OF ISLET TRANSPLANTATION IN NON-UREMIC DIABETIC PATIENTS … Type 1 diabetes is an autoimmune disease in which the insulin-producing pancreatic beta cells are destroyed, resulting in poor blood sugar control. The purpose of this study is to determine the safety and effectiveness of islet transplantation, combined with immunosuppressive medications, specifically using Campath as induction, for treating type 1 diabetes in individuals experiencing hypoglycemia unawareness and severe hypoglycemic episodes. Principal Investigator Borja-Cacho, Daniel ClinicalTrials.gov IdentifierNCT01897688IRB number STU00059469 More Info Keywords Diabetes Islet Pancreas Hypoglycemia T1D Transplant Copy Study URL to Clipboard Copy
Neural Systems for the Dynamic Use of Memory The Laboratory for Human Neuroscience at the Northwestern University Feinberg School of Medicine is seeking participants for research studies on how the brain develops across the lifespan. We are currently enrolling individuals 18-34 years of age in our research studies. Depending on your eligibility, you could take part in … The Laboratory for Human Neuroscience at the Northwestern University Feinberg School of Medicine is seeking participants for research studies on how the brain develops across the lifespan. We are currently enrolling individuals 18-34 years of age in our research studies. Depending on your eligibility, you could take part in studies involving cognitive testing or studies involving noninvasive recording of brain function (using EEG, TMS, and MRI). Please contact us if you are interested in participating and we can determine your eligibility and provide additional details. All studies take place in downtown Chicago on the Northwestern University campus. Individuals will receive monetary compensation for participating, ranging from $10-$40 per hour depending on the experiment. Please contact fill out our participant survey if you are interested at https://redcap.nubic.northwestern.edu/redcap/surveys/?s=w7RfNPbxwJ or contact us at lhn@northwestern.edu or 312-503-5613. Principal Investigator Voss, Joel L IRB number STU00060723 More Info Email Karp, Erica Phone +1 312 503 5613 Copy Study URL to Clipboard Copy
Noninvasive Manipulation of Hippocampal-Cortical Brain Networks and Memory The Laboratory for Human Neuroscience at the Northwestern University Feinberg School of Medicine is seeking participants for research studies on how the brain develops across the lifespan. We are currently enrolling individuals 18-34 years of age in our research studies. Depending on your eligibility, you could take part in … The Laboratory for Human Neuroscience at the Northwestern University Feinberg School of Medicine is seeking participants for research studies on how the brain develops across the lifespan. We are currently enrolling individuals 18-34 years of age in our research studies. Depending on your eligibility, you could take part in studies involving cognitive testing or studies involving noninvasive recording of brain function (using EEG, TMS, and MRI). Please contact us if you are interested in participating and we can determine your eligibility and provide additional details. All studies take place in downtown Chicago on the Northwestern University campus. Individuals will receive monetary compensation for participating, ranging from $10-$40 per hour depending on the experiment. Please fill out our participant survey if you are interested at https://redcap.nubic.northwestern.edu/redcap/surveys/?s=w7RfNPbxwJ or contact us at lhn@northwestern.edu or 312-503-5613. Principal Investigator Voss, Joel L IRB number STU00070522 More Info Email Karp, Erica Phone +1 312 503 5613 Copy Study URL to Clipboard Copy
OPT2MOVE About the StudyOpt2Move is a 6-month smartphone-based study to help adolescent and young adult cancer survivors become more active.What’s involved? AssessmentsComplete before starting study and at 3 and 6 months: 45-min online surveyWear activity monitor 24/7 for 7 days You will be compensated for … About the Study Opt2Move is a 6-month smartphone-based study to help adolescent and young adult cancer survivors become more active. What’s involved? Assessments Complete before starting study and at 3 and 6 months: 45-min online survey Wear activity monitor 24/7 for 7 days You will be compensated for assessment completion Physical Activity Program All Participants Receive Fitbit, Opt2Move app, exercise prescription, 15-min orientation call Track physical activity with Fitbit and use Opt2Move app daily Additionally, you may receive 0-4 additional Opt2Move features focused on mindfulness and/or social support. How can I learn more? For questions: Phone: 312-503-3465; Email: O2M@nm.org To complete online screening: https://redcap.link/O2M Eligibility Criteria Who can participate? Adults (18-39) diagnosed with cancer (except non-melanoma skin cancer) at age 18-39 5 years or less since cancer diagnosis 3 months or more since completed primary treatment (i.e., surgery, chemotherapy, and/or radiation); may still be undergoing endocrine or hormonal therapies Fluent in spoken and written English Own a smartphone that is either an iPhone (version 5 or greater) or an Android (version 5.0 or greater) Have internet access Have no absolute contraindications to exercise (e.g., acute myocardial infarction, severe orthopedic conditions, or metastatic disease) OR willing to obtain medical clearance from a primary care physician if necessary Engage in less than 60 minutes total each week of moderate to vigorous intensity physical activities such as walking, biking, or swimming Willing to find a Buddy (someone who knows about your cancer and participation in this study and who is willing to participate by supporting you during the 6-month study) Principal Investigator Phillips, Siobhan M ClinicalTrials.gov IdentifierNCT05375162IRB number STU00210628 More Info Keywords cancer young adult eHealth remote app-delivered physical activity Email Horowitz, Bruriah E Phone +1 312 503 3465 Copy Study URL to Clipboard Copy

Follow MSS on Twitter LinkedIn